Atropine eye drops for nearsighted children
Part of Eyes & vision clinical trials.
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 4 and 16 years old.
- They have nearsightedness of at least -1.00 diopters (a standard eye test measurement).
- Their astigmatism (blur from an irregularly shaped cornea) is less than -2.50 diopters.
- They haven't used atropine drops, pirenzipine, or contact lenses before.
- They don't have certain health conditions like Marfan syndrome, Stickler syndrome, or a history of eye surgery.
- They are not allergic to atropine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether atropine eye drops can slow down worsening nearsightedness in children. It is for children whose nearsightedness is getting worse quickly and who have not tried other treatments.
This study tests if using atropine eye drops in increasing doses can prevent nearsightedness (myopia) in children who are at risk. It is for children aged 6 to 9 who do not yet need glasses but have early signs of developing myopia.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
Hear when a new Focus on Axial Length trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.